CDH1 gene as a prognostic biomarker in HCV (genotype 4) induced hepatocellular carcinoma in the Egyptian patients

Theodor Bilharz Research Institute

Bibliographic Information

Authors: El-Araby R.E.; Khalifa M.A.; Zoheiry M.M.; Zahran M.Y.; Rady M.I.; Ibrahim R.A.; El-Talkawy M.D.; Essawy F.M.

Journal: Gene Reports

Publisher: Elsevier Inc

Publication Date: September 2019

Volume / Issue: Volume 16

Article No.: 100452

ISSN: 24520144

DOI: 10.1016/j.genrep.2019.100452

Scopus: View on Scopus

Document Type: Article


Authors and Affiliations

El-Araby R.E., Central Lab, Theodor Bilharz Research Institute (TBRI), Ministry of Scientific Research, Egypt; Khalifa M.A., Zoology Department, Faculty of Science, Al-Azhar University, Egypt; Zoheiry M.M., Immunology Research Department, Theodor Bilharz Research Institute (TBRI), Ministry of Scientific Research, Egypt; Zahran M.Y., Clinical Laboratory, Research Department, Theodor Bilharz Research Institute (TBRI), Ministry of Scientific Research, Egypt; Rady M.I., Zoology Department, Faculty of Science, Al-Azhar University, Egypt; Ibrahim R.A., Hepatoastroenterology Department, Theodor Bilharz Research Institute (TBRI), Ministry of Scientific Research, Egypt; El-Talkawy M.D., Hepatoastroenterology Department, Theodor Bilharz Research Institute (TBRI), Ministry of Scientific Research, Egypt; Essawy F.M., Clinical Laboratory, Research Department, Theodor Bilharz Research Institute (TBRI), Ministry of Scientific Research, Egypt


Abstract

Patients with hepatocellular carcinoma (HCC) have indigent in prognosis tools due to being diagnosed at the latest stages. It's crucial to identify efficient biomarkers that can get better overall diagnosis and treatment of HCC. In the current work, we examined prototypical type I cadherin (CDH1) expression in chronic liver disease (CLD) due to HCV genotype 4 infection with/without cirrhosis and HCC patients as an attempt to evaluate the potential benefits of this new circulating, noninvasive, prognostic, biomarkers for liver cirrhosis and carcinogenesis of Egyptian patients. Eighty subjects were included in this study, divided into two groups; Group I (40 patients) were classified into Group Ia (CLD without cirrhosis, n = 18) and Group Ib (CLD with cirrhosis, n = 22), Group II (CLD patients with HCC, n = 20), and control (Healthy volunteer, n = 20). The expression of CDH1 gene was analyzed by Real-Time PCR. CDH1 showed a persistent and significant downregulation in all diseased groups, which was inconsistency with the progression of the disease toward the HCC stage. In addition, it showed a diagnostic ability to discriminate between cases of HCC against CLD with/without cirrhosis (p < 0.001). Furthermore, CDH1 gene could be considered as a predictor and prognostic parameters for HCC (OR = 0.15, 95% CI 0.033–0.677, p = 0.01), but it was not suitable for use as a predictor for cirrhotic patients. Finally, the gradual decline of CDH1 gene expression with disease progression prompts us to use it as noninvasive prognostic biomarkers for HCV induced liver cirrhosis and HCC in HCV Genotype 4 patients. Abbreviations list: [Table presented] © 2019 Elsevier Inc.


Keywords

CDH1; Cirrhosis; CLD; Genotype IV; HCC; HCV; Prognostic biomarker; alanine aminotransferase; albumin; alpha fetoprotein; aspartate aminotransferase; beta actin; bilirubin; messenger RNA; uvomorulin; adult; Article; cancer prognosis; chronic liver disease; clinical article; controlled study; disease exacerbation; Egyptian; female; gene expression; Hepatitis C virus genotype 4; human; liver cell carcinoma; liver cirrhosis; male; priority journal; real time polymerase chain reaction


Citation Information

Scopus Citations: 1


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]

Multifunctional polycaprolactone-based composite fibers with icariin and glutathione for effective repair of critical-sized bone defects